AI-designed proteins can carry a watermark and still bind their targets
DeepMind has demonstrated watermarked protein binders in the laboratory, a step toward tracing AI-designed biology whose marks can still be deliberately removed.
An AI-designed protein can lose its accompanying paperwork as it moves between a model, a laboratory and a database.
Google DeepMind's SynthID Bio announcement describes a way to make part of that provenance travel within the design itself: a detectable pattern in the amino-acid sequence. The September 30 research gives laboratories a concrete starting point for identifying designs from participating models without relying only on a removable file label.
The peer-reviewed Nature study tested binders against three protein targets. It began with 15 previously successful structural backbones per target, then generated new sequences with or without a watermark. Across 756 sequences, excluding parent designs and controls, the researchers found no significant population-level shift in binding affinity. This is evidence from selected, already promising structures; it does not establish that watermarking preserves every protein's function.
One qualification is visible in the results. At the looser binding threshold shown below, 150 of 222 unwatermarked designs were hits, compared with 155 of 267 designs using one watermark setting. That difference was statistically significant. At the stricter threshold, the study found no significant hit-rate differences. The other practical limit is deliberate removal: the researchers showed that resequencing can erase the signal.
The useful advance is an experimentally tested provenance mechanism. A positive watermark could help synthesis providers or database curators identify a design's origin. It cannot certify that the protein is safe, and an absent watermark cannot establish a natural origin. DeepMind says wider use still requires further research and cooperation across the field.
Take it further
Inspect the paper and original figures Open access. Research evidence, not a clinical treatment or a deployed screening standard.
Inspect code and binding data Public repository for research evaluation. Code, third-party components and model weights have distinct license terms; no application deadline.
Sources & details 3 sources
Discuss in your voice app
Take the reporting, visual explanations and original sources into a conversation. Copy the brief, paste it into your preferred assistant, then start its voice mode.
Paste the brief into your voice app to discuss this reporting.Revised 4 October 2026. Reporting and visuals refined. Original source dates and prior checks retained.
Reporting sources
- Nature: study, methods and original Figure 2
Published September 30, 2026. Full open-access methods and results inspected; Figure 2 supplied exact hit counts. CC BY 4.0.
- Google DeepMind: SynthID Bio announcement
September 30, 2026. Primary developer account of intended uses and remaining adoption work; these are prospective applications.
- Google DeepMind: released code and laboratory data
Repository inspected October 1, 2026. Sequence code and data are public; structure-weight access uses separate instructions and terms.
Images & figures
Measured hit rates pooled across three targets. Each panel uses the same 222 unwatermarked and 267 designs per watermark setting; smaller dissociation constants mean stronger binding. All began from previously successful backbones. Bars show observed proportions, without uncertainty intervals. Watermark A: distortionary sampling at 0.1; B: non-distortionary sampling at 0.5.
Nature, Figure 2b and laboratory methods